Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

171599-83-0

Sildenafil citrate

171599-83-0
24916-52-7

Spiramycin III

24916-52-7
NA

2,3-Dehydro Simvastatin Acid Sodium Salt

NA
83-48-7

Stigmasterol

83-48-7
23307-72-4

Sulfaclozine sodium

23307-72-4
61-47-2

Serotonin creatinine sulfate monohydrate

61-47-2
110871-86-8

Sparfloxacin

110871-86-8
127-71-9

Sulfabenzamide

127-71-9
144-80-9

Sulfacetamide

144-80-9
651-06-9

Sulfameter

651-06-9
729-99-7

Sulfamoxole

729-99-7
526-08-9

Sulfaphenazole

526-08-9
515-64-0

Sulfisomidine

515-64-0
37514-39-9

Sulfisozole sodium

37514-39-9
79902-63-9

Simvastatin

79902-63-9
55721-31-8

Salinomycin sodium salt

55721-31-8
220119-17-5

Selamectin

220119-17-5
4697-68-1

speciophylline UNCARINE D (P)

4697-68-1
21736-83-4

Spectinomycin 2HCl

21736-83-4
486460-32-6

Sitagliptin

486460-32-6